Leveraging AI, researchers have identified a naturally occurring molecule that can suppress appetite and facilitate weight loss in mice and pigs.

Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (sold as Ozempic or Wegovy), mimic ... gene expression that are not attributable to modification of the DNA sequence itself.

Back to Healio The rapid increase in the use of glucagon-like peptide-1 receptor agonists ... GLP-1 drugs, such as semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro, Eli Lilly ...

Table 01: Global Peptide Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2020-2035 Table 02: Global Peptide Therapeutics Market Value (US$ Mn) Forecast, by Application, 2020-2035 Table ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Understand how semaglutide shows strong benefits in MASH treatment, improving liver health and reducing weight.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...